Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125689541 | 12568954 | 1 | I | 20160520 | 20160610 | 20160719 | 20160719 | PER | US-ASTRAZENECA-2016SE65096 | ASTRAZENECA | 21604.00 | DY | M | Y | 85.70000 | KG | 20160719 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125689541 | 12568954 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 36540 | MG | 21366 | 20 | MG | TABLET | QD | |||||
125689541 | 12568954 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 36540 | MG | 21366 | 20 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125689541 | 12568954 | 1 | Blood cholesterol abnormal |
125689541 | 12568954 | 2 | Low density lipoprotein increased |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125689541 | 12568954 | Blood cholesterol increased | |
125689541 | 12568954 | Intentional product misuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125689541 | 12568954 | 1 | 2011 | 0 | ||
125689541 | 12568954 | 2 | 2011 | 0 |